138890-97-8

Basic information

• Product Name: 3,4-Dihydro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide
• Synonyms: 3,4-Dihydro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide;4-Hydroxy-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine 1,1-dioxide
• CAS NO: 138890-97-8
• Molecular Formula: C6H7NO3S2
• Molecular Weight: 205.25468
• Mol File: 138890-97-8.mol

Chemical Properties

• Boiling Point: 410.6°C at 760 mmHg
• Flash Point: 202.1°C
• Appearance: /
• Density: 1.637
• Vapor Pressure: 1.77E-07mmHg at 25°C
• Refractive Index: 1.656
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3,4-Dihydro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-Dihydro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide(138890-97-8)
• EPA Substance Registry System: 3,4-Dihydro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide(138890-97-8)

Safety Data

• Hazardous Substances Data: 138890-97-8(Hazardous Substances Data)

Usage

Uses

Used in Cardiovascular Applications:
3,4-Dihydro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide is used as a calcium channel blocker in the pharmaceutical industry for the treatment of high blood pressure and angina. It helps to lower blood pressure and reduce the workload on the heart by relaxing the blood vessels and increasing the supply of blood and oxygen to the heart.
Used in Pharmaceutical Formulations:
3,4-Dihydro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide is used in various pharmaceutical formulations, such as tablets, capsules, and injections, to ensure effective and convenient administration of the medication. It is typically taken orally and should be used as prescribed by a doctor, following the recommended dosage and instructions for use.

InChI:InChI=1/C6H7NO3S2/c8-5-3-7-12(9,10)6-4(5)1-2-11-6/h1-2,5,7-8H,3H2

Upstream product

• 138890-88-7 3-Acetylthiophene-2-sulfonamide 
• 154127-28-3 3-(2-bromoacetyl)thiophene-2-sulfonamide 

Relevant articles and documents

SULFONAMIDE INHIBITORS OF CARBONIC ANHYDRASE

The present invention relates to new sulfonamide inhibitors of carbonic anhydrase activity, pharmaceutical compositions thereof, and methods of use thereof.

Carbonic anhydrase inhibitors

Compounds of the following formula are disclosed: Compounds of Formula I are the topic of this invention: STR1 Wherein G, J and the two atoms of the thiophene ring to which they are attached form a six-membered ring chosen from STR2 The compounds are usef

Sulfonamides useful as carbonic anhydrase inhibitors

Sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.

Thiophene sulfonamides useful as carbonic anhydrase inhibitors

Thiophene sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.